Vitenskapelig artikkel

• Bente Sandvei Skeie; Alexander R. Craven; Eli Renate Grüner et al. (2026). Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. (ekstern lenke)
• Bente Sandvei Skeie; Linda Sleire; Eli Renate Grüner et al. (2026). Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma. (ekstern lenke)
• Bente Sandvei Skeie; Jian Wang; Ernest Dodoo et al. (2013). Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a Human GBM Xenograft Model. (ekstern lenke)
• Sidsel Marit Bragstad; Marianne Flatebø; Gerd Karin Natvig et al. (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. (ekstern lenke)
• Joshua D. McBriar; Michael Schulder; Bente Sandvei Skeie (2023). First use of radiation for the treatment of arteriovenous malformation. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. (ekstern lenke)
• Lea Starck; Bente Sandvei Skeie; Hauke Bartsch et al. (2022). Arterial input functions in dynamic susceptibility contrast MRI (DSC-MRI) in longitudinal evaluation of brain metastases. (ekstern lenke)
• Linda Sleire; Bente Sandvei Skeie; Inger Anne Netland et al. (2015). Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc<sup>-</sup>, leading to glutathione depletion. (ekstern lenke)
• Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. (ekstern lenke)
• Lea Starck; Bente Sandvei Skeie; Gunnar Moen et al. (2022). Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jonathan Knisely et al. (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. (ekstern lenke)
• Bente Skeie; Per Øyvind Enger; Jan C Brøgger et al. (2012). Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. (ekstern lenke)
• Bente Sandvei Skeie; Geir Egil Eide; Marianne Flatebø et al. (2016). Quality of life is maintained using Gamma Knife radiosurgery: A prospective study of a brain metastases patient cohort. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jeremy Christopher Ganz et al. (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. (ekstern lenke)
• Maziar Behbahani; Geir Olve Skeie; Geir Egil Eide et al. (2019). A prospective study of the natural history of incidental meningioma-Hold your horses!. (ekstern lenke)
• Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. (ekstern lenke)
• Torbjørn Austveg Strømsnes; Morten Lund-Johansen; Geir Olve Skeie et al. (2023). Growth dynamics of incidental meningiomas: A prospective long-term follow-up study. (ekstern lenke)
• Antonio Santacroce; Constantin Tuleasca; Roman Liščák et al. (2022). Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas: A Multicentre Study and Review of the Literature. (ekstern lenke)
• Per Øyvind Enger; Geir Olve Skeie; Frits Alan Thorsen et al. (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. (ekstern lenke)
• Ernest Dodoo; Beate Huffmann; Inti Peredo et al. (2014). Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Linda Sleire; Hilde Elise Førde-Tislevoll; Inger Anne Netland et al. (2017). Drug repurposing in cancer. (ekstern lenke)
• Bente Sandvei Skeie (2021). Lars Leksell - stereotaksiens far. (ekstern lenke)

Konferanseabstrakt

• Hilde Elise Sundøy Førde; Inger Anne Netland; Linda Sleire et al. (2013). COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. (ekstern lenke)
• Linda Sleire; Bente Sandvei Skeie; Inger Anne Netland et al. (2013). Sulfasalazine sensitizes glioblastoma cells to radiation treatment. (ekstern lenke)

Konferanseforedrag

• Lea Starck; Bente Sandvei Skeie; Hauke Bartsch et al. (2020). Robust DSC parameter estimations in patients with brain tumour metastases. (ekstern lenke)
• Bente Sandvei Skeie (2024). A phase 2 trial evaluating anti-tumor efficacy of sulfasalazine in combination with gamma knife surgery for recurrent glioblastoma multiforme. (ekstern lenke)
• Bente Sandvei Skeie (2023). Phase I trial of sulfasalazine combined with stereotactic radiosurgery for recurrent glioblastoma: study protocol and preliminary results for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Geir Olve Skeie et al. (2001). Gamma Knife Radiosurgery of meningiomas involving the cavernous sinus. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Katarzyna Pazdyk Goplen et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Shahin Sarowar et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2023). NCT04205357 – a phase I trial investigating Sulfasalazine as radiosensitizer in combination with Gamma Knife Radiosurgery for recurrent Glioblastoma and a Study protocol for a multicenter phase 2/3 trial.. (ekstern lenke)

Forelesning

• Bente Sandvei Skeie (2023). Meet the expert session: Management of vestibular schwannomas - Radiation therapy options. (ekstern lenke)
• Bente Sandvei Skeie (2022). SRS for drug resistant trigeminal neuralgia. (ekstern lenke)
• Bente Sandvei Skeie (2022). Chair: Radiosurgery section, Asian and Australasian Society of Neurological Surgeons (AACNS) Meeting 2022. (ekstern lenke)
• Bente Sandvei Skeie (2024). Stereotactic radiosurgery and Trigeminal Neuralgia. (ekstern lenke)
• Bente Sandvei Skeie (2024). Stereotactic radiosurgery and vestibular schwannomas. (ekstern lenke)
• Bente Sandvei Skeie (2022). SRS for Glioblastoma. (ekstern lenke)
• Bente Sandvei Skeie (2011). Gamma Knife Treatment of cerebral metastases from colorectal cancer.. (ekstern lenke)

Doktorgradsavhandling

• Bente Sandvei Skeie (2014). Gamma Knife Surgery for Intracranial Tumours – Clinical and Experimental studies. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.